Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Phase II Results Positive For CombinatoRx's Asthma Drug

April 19, 2006

By Jennifer Boggs

FermaVir's Antiviral Portfolio Soon To Start Clinical Testing

April 18, 2006

By Jennifer Boggs

FermaVir's Antiviral Portfolio Soon To Start Clinical Testing

April 18, 2006

By Jennifer Boggs

YM Gaining Subsidiary Via Eximias Acquisition

April 17, 2006

By Jennifer Boggs

YM Gaining Subsidiary Via Eximias Acquisition

April 17, 2006

By Jennifer Boggs

BIO 2006 convention: Development moving forward in non-embryonic stem cells

April 14, 2006

By Jennifer Boggs

Development Moving Forward In Non-Embryonic Stem Cells

April 13, 2006

By Jennifer Boggs

BIO 2006 convention: Clinton: genetically enhanced crops, biofuel way of the future

April 13, 2006

By Jennifer Boggs

Development Moving Forward In Non-Embryonic Stem Cells

April 13, 2006

By Jennifer Boggs

Clinton: Genetically Enhanced Crops, Biofuel Way Of Future

April 12, 2006

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.